No profile data available.
Xtant Medical Holdings, Inc. (XTNT) is a healthcare company in the bone and joint treatment equipment industry, based in Belgrade, United States, with about 151 full-time employees.
It reported revenue of $117.27 million for fiscal year 2024, up 28.4% from fiscal year 2023, and net income of -$16.45 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $33.26 million, up 19.0% from a year before. United States was its largest region in fiscal year 2025, with 91% of revenue. Its market capitalization was $45.73 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally.
Xtant Medical reported $117.27 million in revenue for fiscal year 2024, up 28.4% from $91.30 million in fiscal year 2023. In Q3 2025 revenue was $33.26 million.
United States: 91% of revenue by region in fiscal year 2025, followed by Rest of World (9%).
$45.73 million as of October 9, 2026.
Listed companies of a similar size in the same industry (bone and joint treatment equipment) include Treace Medical Concepts, Inc. (TMCI), Monogram Technologies Inc. (MGRM), Myomo, Inc. (MYO), Lifeward Ltd. (LFWD).